CXCR1 and melanoma: Studies with neutralizing antibodies to either CXCR1 and CXCR2 showed inhibition of MC proliferation and invasive potential whereas in athymic nude mice oral administration of CXCR1/2 antagonists, inhibited the growth and angiogenesis of implanted human melanoma tumors [196].